India’s Supreme Court has rejected a plea by Novartis to patent an updated version of its cancer drug, Glivec. The Swiss drugmaker had been denied a patent by Indian authorities Read More
- News
- Corporate Updates
- Magazine
- Current Issue
- Debate
- Development
- EHR/EMR
- Interview
- Expert Corner
- Government News
- Solution
- Health Business
- Health Financing/Insurance
- Health Issues
- Health IT
- Health Policy
- Hospital News
- India
- Global
- International
- Medical Technology
- Product Watch
Novartis loses Indian patent case
